首页> 外文期刊>The Lancet >A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.
【24h】

A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.

机译:三硝酸甘油酯软膏治疗肛裂的随机,前瞻性,双盲,安慰剂对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Anal fissure is most commonly treated surgically by internal anal sphincterotomy. However, there is some concern over the effects of this procedure on continence. Nitric oxide donors such as glyceryl trinitrate (GTN) have been shown to cause a reversible chemical sphincterotomy capable of healing fissures in a small series of cases. This study reports a prospective, randomised, double-blind, placebo-controlled trial to test the hypothesis that topical GTN is the best first-line treatment for chronic anal fissure. METHODS: 80 consecutive patients were randomised to receive treatments with topical 0.2% GTN ointment or placebo. Maximum anal resting pressure (MARP) was measured with a constantly perfused side-hole catheter before and after the first application of trial ointment. Anodermal blood flow was measured during manometry by laser Doppler flowmetry. After initial treatments, patients were given a supply of ointment (either GTN or placebo) to be applied to the lower anal canal twice daily. Patients were reviewed 2-weekly. At the initial and follow up visits patients were asked to record pain experienced on defaecation on a linear analogue pain score. Endpoints were healing of the fissure or condition after 8 weeks of treatment. FINDINGS: After 8 weeks, healing was observed in 26/38 (68%) patients treated with GTN and in 3/39 (8%) patients treated with placebo (p < 0.0001, chi 2 test). Linear analogue pain score fell significantly in both groups after 2 weeks of treatment. This fall was maintained in those treated with GTN but pain scores returned to pre-treatment values by 4 weeks on treatment with placebo. MARP fell significantly from a mean of 115.9 (SD 31.6) to 75.9 (30.1) cm H2O (p < 0.001, Student's paired t-test) in patients treated with GTN but no change was seen in MARP after placebo. Anodermal blood flow measured by laser Doppler flowmetry significantly increased after application of GTN ointment but was unaffected by placebo. INTERPRETATION: Topical GTN provides rapid, sustained relief of pain in patients with anal fissure. Over two-thirds of patients treated in this way avoided surgery which would otherwise have been required for healing. Long-term follow up is needed to assess the risk of recurrent fissure in patients with GTN.
机译:背景:肛裂最常见的手术方法是肛门内括约肌切开术。但是,对此程序对节制的影响有些担忧。一氧化氮供体,例如三硝酸甘油酯(GTN),已显示出可在少数情况下治愈裂隙的可逆化学括约肌切开术。这项研究报告了一项前瞻性,随机,双盲,安慰剂对照试验,以检验外用GTN是慢性肛裂最佳一线治疗的假设。方法:80例连续患者被随机分配接受局部0.2%GTN软膏或安慰剂治疗。在首次使用试验药膏前后,使用持续灌注的侧孔导管测量最大肛门静息压力(MARP)。在测压期间通过激光多普勒血流仪测量无表皮血流量。最初的治疗后,每天两次给患者提供软膏(GTN或安慰剂),用于下肛管。患者每2周检查一次。在初诊和随访中,要求患者记录线性模拟疼痛评分上的排便经历的疼痛。终点是治疗8周后裂缝或状况的愈合。结果:8周后,在接受GTN治疗的26/38(68%)患者和接受安慰剂治疗的3/39(8%)患者中观察到了愈合(p <0.0001,χ2检验)。治疗2周后,两组的线性类似物疼痛评分均显着下降。在使用GTN的患者中,这种跌幅得以保持,但在使用安慰剂治疗4周后,疼痛评分恢复到治疗前的水平。接受GTN治疗的患者的MARP从均值115.9(SD 31.6)显着下降至75.9(30.1)cm H2O(p <0.001,Student's paired t-test),但安慰剂治疗后MARP无变化。施用GTN软膏后,通过激光多普勒血流仪测量的无表皮血流量显着增加,但不受安慰剂影响。解释:外用GTN可使肛裂患者的疼痛持续快速缓解。以这种方式治疗的患者中,三分之二以上避免了手术,否则将需要进行手术治疗。需要长期随访以评估GTN患者复发裂痕的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号